High-dose, frequently administered interferon beta therapy for relapsing–remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study

Pierangelo Barbero, E. Verdun, Mauro Bergui, A. Pipieri, Marinella Clerico, Angele Cucci, Alessandra Ricci, B. Bergamasco, Luca Durelli

Journal of the Neurological Sciences · 2004 · 32 citations · 27 references

Concepts

References

27